S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Stock market today: Asian markets sink, with Japan’s Nikkei down 3.5%, as Mideast tensions flare
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Stock market today: Asian markets sink, with Japan’s Nikkei down 3.5%, as Mideast tensions flare
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Stock market today: Asian markets sink, with Japan’s Nikkei down 3.5%, as Mideast tensions flare
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Stock market today: Asian markets sink, with Japan’s Nikkei down 3.5%, as Mideast tensions flare
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China

Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Invesco BulletShares 2028 High Yield Corporate Bond ETF stock logo
BSJS
Invesco BulletShares 2028 High Yield Corporate Bond ETF
$21.27
$21.55
$20.05
$21.84
$172.29M0.4670,719 shs64,760 shs
Belgravia Capital International Inc, stock logo
ICP
Belgravia Capital International Inc,
C$0.06
C$0.02
C$0.12
C$14.59MN/A698,779 shs8.14 million shs
MJO
MicroSectors Cannabis 2X Leveraged ETNs
$81.16
+2.2%
$81.16
$71.62
$209.04
$16.23MN/A2,043 shs1,000 shs
Pernix Therapeutics Holdings, Inc. stock logo
PTX
Pernix Therapeutics
$0.16
$0.20
$3.30
$419K1.23.04 million shs16,105 shs
Investing Strategies To Help Grow Your Retirement Income Cover

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Invesco BulletShares 2028 High Yield Corporate Bond ETF stock logo
BSJS
Invesco BulletShares 2028 High Yield Corporate Bond ETF
+0.09%-0.79%-1.02%-1.30%+0.47%
Belgravia Capital International Inc, stock logo
ICP
Belgravia Capital International Inc,
0.00%0.00%0.00%0.00%0.00%
MJO
MicroSectors Cannabis 2X Leveraged ETNs
0.00%0.00%0.00%0.00%0.00%
Pernix Therapeutics Holdings, Inc. stock logo
PTX
Pernix Therapeutics
0.00%0.00%0.00%0.00%0.00%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Invesco BulletShares 2028 High Yield Corporate Bond ETF stock logo
BSJS
Invesco BulletShares 2028 High Yield Corporate Bond ETF
N/AN/AN/AN/AN/AN/AN/AN/A
Belgravia Capital International Inc, stock logo
ICP
Belgravia Capital International Inc,
N/AN/AN/AN/AN/AN/AN/AN/A
MJO
MicroSectors Cannabis 2X Leveraged ETNs
N/AN/AN/AN/AN/AN/AN/AN/A
Pernix Therapeutics Holdings, Inc. stock logo
PTX
Pernix Therapeutics
N/AN/AN/AN/AN/AN/AN/AN/A

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Invesco BulletShares 2028 High Yield Corporate Bond ETF stock logo
BSJS
Invesco BulletShares 2028 High Yield Corporate Bond ETF
0.00
N/AN/AN/A
Belgravia Capital International Inc, stock logo
ICP
Belgravia Capital International Inc,
N/AN/AN/AN/A
MJO
MicroSectors Cannabis 2X Leveraged ETNs
0.00
N/AN/AN/A
Pernix Therapeutics Holdings, Inc. stock logo
PTX
Pernix Therapeutics
N/AN/AN/AN/A

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Invesco BulletShares 2028 High Yield Corporate Bond ETF stock logo
BSJS
Invesco BulletShares 2028 High Yield Corporate Bond ETF
N/AN/AN/AN/AN/AN/A
Belgravia Capital International Inc, stock logo
ICP
Belgravia Capital International Inc,
N/AN/AN/AN/AN/AN/A
MJO
MicroSectors Cannabis 2X Leveraged ETNs
N/AN/AN/AN/AN/AN/A
Pernix Therapeutics Holdings, Inc. stock logo
PTX
Pernix Therapeutics
$146.07M0.00N/AN/A($14.77) per share0.00

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Invesco BulletShares 2028 High Yield Corporate Bond ETF stock logo
BSJS
Invesco BulletShares 2028 High Yield Corporate Bond ETF
N/AN/A0.00N/AN/AN/AN/AN/A
Belgravia Capital International Inc, stock logo
ICP
Belgravia Capital International Inc,
N/AN/A0.00N/AN/AN/AN/AN/AN/A
MJO
MicroSectors Cannabis 2X Leveraged ETNs
N/AN/A0.00N/AN/AN/AN/AN/A
Pernix Therapeutics Holdings, Inc. stock logo
PTX
Pernix Therapeutics
-$77.14MN/A0.00N/AN/A-59.70%N/A-37.01%N/A

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Invesco BulletShares 2028 High Yield Corporate Bond ETF stock logo
BSJS
Invesco BulletShares 2028 High Yield Corporate Bond ETF
$1.466.86%N/AN/AN/A
Belgravia Capital International Inc, stock logo
ICP
Belgravia Capital International Inc,
N/AN/AN/AN/AN/A
MJO
MicroSectors Cannabis 2X Leveraged ETNs
N/AN/AN/AN/AN/A
Pernix Therapeutics Holdings, Inc. stock logo
PTX
Pernix Therapeutics
N/AN/AN/AN/AN/A

Latest BSJS, ICP, PTX, and MJO Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
3/15/2024
Invesco BulletShares 2028 High Yield Corporate Bond ETF stock logo
BSJS
Invesco BulletShares 2028 High Yield Corporate Bond ETF
Monthly$0.12043/18/20243/19/20243/22/2024
2/16/2024
Invesco BulletShares 2028 High Yield Corporate Bond ETF stock logo
BSJS
Invesco BulletShares 2028 High Yield Corporate Bond ETF
Monthly$0.11392/20/20242/21/20242/23/2024
1/19/2024
Invesco BulletShares 2028 High Yield Corporate Bond ETF stock logo
BSJS
Invesco BulletShares 2028 High Yield Corporate Bond ETF
Monthly$0.11361/22/20241/23/20241/26/2024
(Data available from 1/1/2013 forward)

Debt

Ownership

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Invesco BulletShares 2028 High Yield Corporate Bond ETF stock logo
BSJS
Invesco BulletShares 2028 High Yield Corporate Bond ETF
147,0008.10 millionN/ANot Optionable
Belgravia Capital International Inc, stock logo
ICP
Belgravia Capital International Inc,
147,000243.24 millionN/ANot Optionable
MJO
MicroSectors Cannabis 2X Leveraged ETNs
147,000200,000N/ANot Optionable
Pernix Therapeutics Holdings, Inc. stock logo
PTX
Pernix Therapeutics
N/A14.51 millionN/AOptionable

BSJS, ICP, PTX, and MJO Headlines

SourceHeadline
Bicycle Therapeutics PLC ADR BCYCBicycle Therapeutics PLC ADR BCYC
morningstar.com - February 23 at 11:30 AM
Alcoholic HepatitisAlcoholic Hepatitis
medscape.com - July 25 at 2:14 PM
Prescient Therapeutics LtdPrescient Therapeutics Ltd
reuters.com - September 26 at 4:20 AM
Those who invested in Prescient Therapeutics (ASX:PTX) three years ago are up 307%Those who invested in Prescient Therapeutics (ASX:PTX) three years ago are up 307%
yahoo.com - August 25 at 2:47 AM
A Builder From The Ground Up, Doug Drysdale, CEO of Cybin: Meet Our SpeakersA Builder From The Ground Up, Doug Drysdale, CEO of Cybin: Meet Our Speakers
msn.com - April 6 at 6:41 PM
Pernix Therapeutics Holdings Inc (PTX)Pernix Therapeutics Holdings Inc (PTX)
investing.com - March 30 at 8:52 PM
Mid-Afternoon Market Update: Vivint Solar Dips After Wider-Than-Expected Q3 Loss; Rackspace Shares Spike HigherMid-Afternoon Market Update: Vivint Solar Dips After Wider-Than-Expected Q3 Loss; Rackspace Shares Spike Higher
finance.yahoo.com - October 26 at 1:58 AM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Company Descriptions

Invesco BulletShares 2028 High Yield Corporate Bond ETF logo

Invesco BulletShares 2028 High Yield Corporate Bond ETF

NASDAQ:BSJS
The Invesco BulletShares 2028 High Yield Corporate Bond ETF (BSJS) is an exchange-traded fund that mostly invests in high yield fixed income. The fund tracks a market-value-weighted index of USD-denominated corporate high yield bonds with effective maturities in 2028. BSJS was launched on Sep 16, 2020 and is managed by Invesco.
Belgravia Capital International Inc, logo

Belgravia Capital International Inc,

TSE:ICP
Belgravia Capital International Inc, formerly known as IC Potash Corp, is a Canada-based company focused on the provision of value-added services to the international Cannabis industry. The Company's activities include the production of specialized organic fertilizers for Cannabis plants, as well as research and development in the area of agronomics through its wholly owned subsidiary, ICP Organics Corp. Additionally, the Company is engaged in the development of blockchain technology software to support the cultivation and distribution processes, such as seed to sale tracking and quality attestation of intermediate and consumer products. The Company is also developing a royalty-streaming subsidiary.

MicroSectors Cannabis 2X Leveraged ETNs

NYSEARCA:MJO
Pernix Therapeutics logo

Pernix Therapeutics

NASDAQ:PTX
Pernix Therapeutics Holdings, Inc., a specialty pharmaceutical company, focuses on the acquisition, development, and commercialization of prescription drugs primarily for the United States market. It targets underserved therapeutic areas, such as central nervous system (CNS), including pain, neurology, and psychiatry. The company's products comprise Zohydro ER with BeadTek, an opioid agonist indicated for the management of pain; Silenor, a non-narcotic, non-scheduled, and non-addictive prescription sleep aid for the treatment of insomnia characterized by difficulty with sleep maintenance; and Treximet, a fixed dose combination product indicated for the treatment of acute migraine. Pernix Therapeutics Holdings, Inc. markets and sells its non-core products, including generics through its wholly owned subsidiaries; and markets its non-promoted products through distributors and trade partners. It serves drug wholesalers, specialty pharmacies, retail drug stores, mass merchandisers, and grocery store pharmacies. Pernix Therapeutics Holdings, Inc. was founded in 1996 and is headquartered in Morristown, New Jersey.